#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Uterine leiomyosarcoma Chronic graft versus host disease Mucopolysaccharidosis III Polycystic liver disease Acute lymphocytic leukaemia recurrent Infertility female Ependymoma Sarcoma Soft tissue necrosis Small intestine leiomyosarcoma Nephroblastoma Diffuse large B-cell lymphoma recurrent Subdural haematoma Anaplastic large cell lymphoma T- and null-cell types Enteritis More trials…

    Learn about Rare Diseases

    Haemophilia A with anti factor VIII – Treatment Waldenstrom’s macroglobulinaemia – Trials in Disease Rhabdomyosarcoma recurrent – Life with Disease Pituitary-dependent Cushing’s syndrome – Treatment Angiosarcoma non-metastatic – Diagnostics Activated PI3 kinase delta syndrome – Diagnostics Nephrotic syndrome – Basic Information Acquired haemophilia – Trials in Disease Pelizaeus-Merzbacher disease – Treatment Synovial sarcoma recurrent More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dexamethasone Azd0305 Bhv-7000 Alogliptin Losartan AZD1163 Tilsotolimod Sodium Vx-522 CAMOSTAT MESILATE Human Plasma Protein Timolol Enlicitide Chloride Methotrexate Disitamab Vedotin Tetracycline Hydrochloride L-Ascorbic Acid Axitinib Avibactam Sodium AUROCELL-TX BENZYLPENICILLIN PROCAINE More therapies…

    Learn about Your Condition

    Myelodysplastic syndrome Infertility female Arterial stiffness Measles Pancreatic carcinoma recurrent Vulvovaginal pain Glioblastoma multiforme Immune thrombocytopenia Cutaneous T-cell lymphoma Pseudomyxoma peritonei Barrett's oesophagus Genital herpes simplex Complicated appendicitis Peyronie's disease Sepsis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hemic and Lymphatic Diseases

  • Study on Venetoclax, Azacitidine, and Donor Lymphocyte Infusion for Patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia Relapse After Transplantation

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • Azacitidine
    • Venetoclax
    France

  • Study of Mitapivat for Patients with Sickle Cell Disease and Kidney Disease

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Sickle cell disease
    Investigated Drugs:
    • Mitapivat
    France Ireland

  • Study Comparing Acalabrutinib to Standard Treatments for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Acalabrutinib
    Croatia Czechia Hungary Poland

  • Study on WT1 mRNA DC Vaccine to Prevent Relapse in Adults with Acute Myeloid Leukemia

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Wt1 Mrna Dc
    Belgium

  • Study on the Safety and Effectiveness of Venetoclax, Atezolizumab, and Obinutuzumab for Patients with Richter Syndrome from Chronic Lymphocytic Leukemia

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Richter’s syndrome
    Investigated Drugs:
    • Obinutuzumab
    • Venetoclax
    • Atezolizumab
    Italy

  • Comparison of intravenous versus subcutaneous isatuximab with lenalidomide, bortezomib and dexamethasone in newly diagnosed multiple myeloma patients eligible for transplant

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Isatuximab
    • Betamethasone Sodium Phosphate
    • Bortezomib
    Austria Germany
Previous Page
1 … 60 61 62 63 64 … 89
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!